Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion type Assertion NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_head.
- NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion description "[Significant genes in myeloma plasma cells from patients that were associated with early-onset bortezomib-induced peripheral neuropathy were the enzyme coding genes RHOBTB2 (upregulated by 159 times; p=4510(-5)), involved in drug-induced apoptosis, CPT1C (144 times; p=2910(-7)), involved in mitochondrial dysfunction, and SOX8 (168 times; p=42810(-13)), involved in development of peripheral nervous system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_provenance.
- NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion evidence source_evidence_curated NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_provenance.
- NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion SIO_000772 20864405 NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_provenance.
- NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion wasDerivedFrom ctd_human-20130708 NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_provenance.
- NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_assertion wasGeneratedBy ECO_0000218 NP28512.RA8J54wP5hbmjlU9smyc3038bdVhK-6Aj92BCtPN74lUM130_provenance.